Pregnant women and young children aged <18 years;
Patients with underlying disease cases without the possibility of resuscitation (e.g., terminal cancer);
Patients with do-not-resuscitate (DNR) status;
Death by excessive bleeding (e.g., abdominal main artery rupture);
Patients who have experienced in-hospital CA;
Patients previously treated with steroid, anti-cancer medicine, or immunosuppression treatment before CA;
Patients already been registered with other studies; or
Patients from whom informed consent cannot be obtained
